PMC:7408073 / 86638-86879 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T486","span":{"begin":234,"end":240},"obj":"Body_part"}],"attributes":[{"id":"A486","pred":"fma_id","subj":"T486","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2986","span":{"begin":63,"end":73},"obj":"Gene"},{"id":"2987","span":{"begin":213,"end":217},"obj":"Gene"},{"id":"2989","span":{"begin":93,"end":101},"obj":"Species"},{"id":"2991","span":{"begin":84,"end":92},"obj":"Disease"}],"attributes":[{"id":"A2986","pred":"tao:has_database_id","subj":"2986","obj":"Gene:3827"},{"id":"A2987","pred":"tao:has_database_id","subj":"2987","obj":"Gene:59272"},{"id":"A2989","pred":"tao:has_database_id","subj":"2989","obj":"Tax:9606"},{"id":"A2991","pred":"tao:has_database_id","subj":"2991","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T494","span":{"begin":84,"end":92},"obj":"Disease"}],"attributes":[{"id":"A494","pred":"mondo_id","subj":"T494","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T1039","span":{"begin":218,"end":226},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T1040","span":{"begin":234,"end":240},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40147","span":{"begin":42,"end":53},"obj":"Chemical"},{"id":"T54329","span":{"begin":63,"end":73},"obj":"Chemical"}],"attributes":[{"id":"A1101","pred":"chebi_id","subj":"T40147","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A64187","pred":"chebi_id","subj":"T54329","obj":"http://purl.obolibrary.org/obo/CHEBI_3165"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T154","span":{"begin":20,"end":41},"obj":"http://purl.obolibrary.org/obo/GO_0014863"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T423","span":{"begin":0,"end":241},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma."}